← Open Payments lookup

LAILA NOORUDDIN: Open Payments

NPI 1063731941 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,660 in 77 payments from 17 companies in 2025. Trend: 2023 $1,050 · 2024 $2,023 · 2025 $1,660

Food & beverage: $1,583Education: $77
CompanyPaymentsAmount
ABBVIE INC.19$429
Janssen Biotech, Inc.12$239
Regeneron Healthcare Solutions, Inc.6$158
Takeda Pharmaceuticals U.S.A., Inc.5$131
Ipsen Biopharmaceuticals, Inc4$119
Ardelyx, Inc.5$90
Aimmune Therapeutics, Inc.4$87
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$84
Lilly USA, LLC4$76
Phathom Pharmaceuticals, Inc.3$56

Products named: RINVOQ, TREMFYA, DUPIXENT, IQIRVO, ENTYVIO, IBSRELA, XIFAXAN, OMVOH.

Industry payments across TX — which companies pay providers there.